• Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
  • Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
  • Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
  • Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
  • Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
  • Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test

Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test

Type: IVD Reagent
Certificate: ISO, CE
Shelf Life: 24 Months
Usage: Professional Use
Sample: Whole Blood, Serum, Plasma
Result Time: Within 15 Mins
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
  • Overview
  • Intended Use
  • Introduction
  • Contents
  • Storage & Statibility
  • Sample Collection&Storage
  • Operation
  • Detailed Photos
  • Company Profile
Overview

Basic Info.

Model NO.
CEA-DW02
Principle
Immunochromatography
Storage
2~30ºC
Transport Package
Cartons
Specification
40test/box
Trademark
Dewei
Origin
China
Production Capacity
100, 000PCS/Day

Product Description

Intended Use


The Carcinoembryonic antigen (CEA) Rapid Test (Whole Blood/Serum/Plasma) is a rapid visual immunoassay for the qualitative presumptive detection of human carcinoembryonic antigen (CEA) in human whole blood, serum, or plasma specimens. This kit is intended for use as an aid in the diagnosis of various cancers.

Introduction


Carcinoembryonic antigen (CEA) is a tumor-associated antigen characterized as an oncofetal glycoprotein of approximately 200,000 molecular weight with Beta electrophoretic mobility, a single protein chain of about 800 amino acids, and 50-80% carbohydrate composition. CEA was first present as a specific antigen for adenocarcinoma of the colon. More recent studies have demonstrated CEA presence in a variety of malignancies, particularly those involving ectodermal tissues of gastrointestinal or pulmonary origin. Small amounts have also been demonstrated in secretions from the colonic mucosa. Additionally, CEA-like substances have been reported in normal bile from non-icteric patients. CEA testing can have significant value in the monitoring of patients. Persistent elevation in circulating CEA following treatment is strongly indicative of occult metastic and/or residual disease. A persistent rising CEA value may be associated with progressive malignant disease and poor therapeutic response. A declining CEA value is generally indicative of a favorable prognosis and good response to treatment. Measurement of CEA has been shown to be clinically relevant in the follow-up management of patients with colorectal, breast, lung, prostatic, pancreatic, ovarian, and other carcinomas. Follow-up studies of patients with colorectal, breast and lung carcinomas suggest that the preoperative CEA level has prognostic significance.
 

Contents

 
• Rapid test cassette with desiccant.
• Buffer
• Pipette
• Package insert
 

Storage & Statibility

 
• Store at 2 ~ 30 º C in the sealed pouch for 24 months.
• Keep away from direct sunlight, moisture and heat.
• DO NOT FREEZE.
 

Sample Collection&Storage


• Store at 2 ~ 30 º C in the sealed pouch for 24 months.
• Keep away from direct sunlight, moisture and heat.
• DO NOT FREEZE.

Operation


Bring tests, specimens, buffer and/or controls to room temperature (15- 30°C) before use.
1. Remove the test from its sealed pouch, and place it on a clean, level surface. Label the device with patient or control identification. For best results, the assay
should be performed within one hour.
Using the provided disposable pipette, transfer 1 drop of whole blood, serum or plasma specimen to the specimen well (S) of the cassette, then add 1 drop of
buffer and start the timer.
Avoid trapping air bubbles in the specimen well (S), and do not add any solution to the result window.
As the test begins to work, color will migrate across the membrane.
2. Wait for the colored band(s) to appear. The result should be read within 15 minutes. Do not interpret the result after 20 minutes.
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test


 

 

Detailed Photos

Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test

 

Company Profile

About Us

Carcinoembryonic Antigen (CEA) Tumor Marker Rapid TestDewei Medical Equipment Co., Ltd. is a high-tech enterprise specialized in developing and marketing of Medical Consmuables like Clinical Laboratory analyzer and reagents, Hematology Analyzer and Reagents, Washing Solutions, Urine Sediment Reagents and DNA/RNA Preservation Kits.
During the special period, Dewei also develop the reagent kits, like Virus Transport Medium with swab, Rapid test and Saliva Collection Kits.
Dewei products are widely used in hospital clinics, disease control centers, blood banks, veterinary clinics, scientific research center and college laboratories.

 

R&D team
15% annual sales amount is devoted R&D department.
With professional R&D team, Dewei is continuously making new achievements on innovation, gaining numbers of national invention patents and professional technical awards. Meanwhile, Dewei focuses on the improvement of technology to guarantee product quality and pursue product performance.
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test


Certificate
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test


Production Workshop

Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test


Exhibition
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test

Our Team

Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
 

Transportation
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
Carcinoembryonic Antigen (CEA) Tumor Marker Rapid Test
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
50
Year of Establishment
2020-08-03